Systrade’s BioNTech BNTX Stock Holding History

Systrade’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10,000	Closed	-$930K	–	14
2026 Q2	$930K	Hold	10,000	–	–	0.58%	11
2026 Q1	$889K	Hold	10,000	–	–	0.6%	10
2025 Q4	$952K	Hold	10,000	–	–	0.58%	12
2025 Q3	$986K	Hold	10,000	–	–	0.73%	9
2025 Q2	$1.06M	Hold	10,000	–	–	1.21%	10
2025 Q1	$911K	Hold	10,000	–	–	1.27%	8
2024 Q4	$1.05M	Hold	10,000	–	–	1.79%	8
2024 Q3	$1.05M	Hold	10,000	–	–	2.21%	5
2024 Q2	$804K	Hold	10,000	–	–	1.38%	3
2024 Q1	$922K	Hold	10,000	–	–	1.12%	3
2023 Q4	$1.06M	Sell	10,000 -40,000	-80%	-$4.03M	0.95%	4
2023 Q3	$5.43M	Hold	50,000	–	–	4.7%	3
2023 Q2	$5.4M	Buy	50,000 +40,000	+400%	+$4.5M	6.54%	4
2023 Q1	$1.25M	Hold	10,000	–	–	0.74%	6
2022 Q4	$1.5M	Buy	+10,000	New	+$1.54M	1.29%	6

Other funds holding BNTX

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Slow Capital Greenbrae, California $890M AUM 40.96% 1-Year Est. Return

Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return

Systrade's BNTX Position: Q3 2026 in Review

Systrade sold out of BioNTech (BNTX) in Q3 2026, closing a stake of 10,000 shares — an estimated $930K sold.

Systrade first reported a position in BNTX in Q4 2022 and held it in 15 quarters. The position peaked at $5.43M in Q3 2023. 71 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

Systrade reported no remaining BioNTech position as of Q3 2026 after selling out during the quarter.
Systrade sold 10,000 BioNTech shares in Q3 2026, an estimated $930K.
Systrade first reported a position in BioNTech in Q4 2022 and held it in 15 quarters.
Systrade's BioNTech position peaked at $5.43M in Q3 2023.
71 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Systrade's 13F filing for Q3 2026, filed 9 Oct 2026.